Teleflex Announces Quarterly Dividend of $0.34 per share
WAYNE, PA — Teleflex Incorporated (NYSE: TFX) announced that its Board of Directors declared a quarterly cash dividend of thirty-four cents ($0.34) per share of common stock.
Read MoreCommon stock
Neuronetics, Inc. Adopts Limited Duration Shareholder Rights Plan
MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM), a commercial-stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from …
Read More
Baudax Bio Announces Pricing of Public Offering of Common Stock and Warrants
MALVERN, PA — Baudax Bio, Inc. (Nasdaq: BXRX), a pharmaceutical company focused on therapeutics for acute care settings, today announced the pricing of an underwritten public offering of 7,692,308 shares …
Read More Triumph Group Declares Quarterly Dividend
BERWYN, PA — Triumph Group, Inc. (NYSE: TGI) announced that its Board of Directors has declared a regular quarterly dividend of $0.04 per share on its outstanding common stock.
Read More
Vishay Intertechnology Declares Quarterly Dividend of $0.095 per Share
MALVERN, PA — Vishay Intertechnology, Inc. (NYSE: VSH), one of the world’s largest manufacturers of discrete semiconductors and passive components, announced that the Company’s Board of Directors declared a dividend of $0.095 per …
Read More
UGI Declares Common Dividend of $0.325 per Share
VALLEY FORGE, PA — The Board of Directors of UGI Corporation (NYSE: UGI) has declared a quarterly dividend of $0.325 per share of the company’s common stock.
Read More
Recro Pharma Announces Baudax Bio Common Stock Approved for Listing on the NASDAQ Capital Market
MALVERN, PA — Recro Pharma, Inc. (NASDAQ: REPH), a pharmaceutical company with a high-performing revenue-generating contract development and manufacturing (CDMO) division, announced that the U.S. Securities and Exchange Commission (SEC) has declared effective …
Read More
Ocugen Announces Warrant Restructuring
MALVERN, PA — Ocugen, Inc., (NASDAQ: OCGN), a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing a pipeline of innovative therapies that address rare and underserved eye diseases, announced that it …
Read More
Recro Pharma’s Board of Directors Approves Separation of Acute Care Business Segment and Declares Special Dividend Distribution of Baudax Bio Common Stock
MALVERN, PA — Recro Pharma, Inc. (NASDAQ: REPH), a specialty pharmaceutical company with a high-performing revenue-generating contract development and manufacturing (CDMO) division, announced that its board of directors has approved the planned spin-off …
Read More
USA Technologies Adopts Short Duration Shareholder Rights Plan
MALVERN, PA — USA Technologies, Inc. (OTC: USAT), a cashless payments and software services company that provides end-to-end technology solutions for the self-service retail market, recetly announced that its Board of Directors …
Read More